Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2023

Genmab — Oktober 2023

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #113

    Ser ud til 2407 var bunden for denne gang. Stadig stigende bunde i.f.t den røde støttelinie fra Marts 2020 så på et eller andet tidspunkt burde vi se en ny top. Det hele er nok forsinket p.g.a de nu høje renter som medføre en lavere værdisætning af Genmab. Nyt target er derfor 3500 omkring April-Maj 2024. https://www.proinvestor.com/boards/112093/$/115970

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #114

      og uge kortet https://www.proinvestor.com/boards/112093/$/115971

      1 Reply Last reply
      0
      • V Offline
        V Offline
        Vitus
        wrote on sidst redigeret af
        #115

        Utroligt der er yderst begrænset omsætning i Genmab, når den kan købes til spotpris..

        1 Reply Last reply
        0
        • StockBullS Offline
          StockBullS Offline
          StockBull
          wrote on sidst redigeret af
          #116

          Det er muligvis det som er opkøbernes taktik. Laaangsomt opkøb uden, at drive kursen for højt op.. Nu er alle bange for, at købe og opkøberne kan langsomt akkumulere i fred og ro.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #117

            Novo Nordisk-direktør satser på vækst inden for sjældne sygdomme https://medwatch.dk/Medicinal___Biotek/article16490656.ece?utm_medium=latestNews Han fortæller desuden, at væksten skal bæres af fire nye produkter, hvoraf Mim8, er udviklet i samarbejde med Genmab, der ventes at kommet til at stå for ...

            1 Reply Last reply
            0
            • StockBullS Offline
              StockBullS Offline
              StockBull
              wrote on sidst redigeret af
              #118

              Der er jo en hel del gode triggers kommende 6 mdr og den eneste virkelige negative historie i de sidste mange år er Darzalex patentsagen.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #119

                Janssen Submits Application to the European Medicines Agency for RYBREVANT®▼ (amivantamab) in Combination with Chemotherapy for the First-Line Treatment of Adult Patients with Advanced Non-Small Cell Lung Cancer with Activating EGFR Exon 20 Insertion Mutations https://www.globenewswire.com/news-release/2023/10/06/2755961/0/en/Janssen-Submits-Application-to-the-European-Medicines-Agency-for-RYBREVANT-amivantamab-in-Combination-with-Chemotherapy-for-the-First-Line-Treatment-of-Adult-Patients-with-

                1 Reply Last reply
                0
                • V Offline
                  V Offline
                  Vitus
                  wrote on sidst redigeret af
                  #120

                  Håber da Darzalex patentsagen ender positivt….

                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    JKY_VH
                    wrote on sidst redigeret af
                    #121

                    Det kan vi da håbe Vitus

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #122

                      anything of interest in that medwatch/Novo article?

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #123

                        AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html --> let's start that Tepezza push

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #124

                          Rapport fra Stifel omkring situtationen for biotek https://www.proinvestor.com/boards/115979

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            peter12
                            wrote on sidst redigeret af
                            #125

                            Lidt om gen3014 h2hhttps://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(23)01668-3/pdf

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #126

                              Ja, så mangler vi bare resultaterne. Næsten uudholdeligt spændende. 🙂 Det er ikke store ord, de bruger om de foreløbige resultater: tolerabel sikkerhedsprofil og påvist klinisk aktivitet.

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #127

                                16 mg/kg, det er det samme som IV dara. Så skulle der vel kunne fikses en sc version.

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #128

                                  I givet fald.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #129

                                    Tepkinly European public assessment report if you really have nothing to do this weekend https://www.ema.europa.eu/en/medicines/human/EPAR/tepkinly

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      peter12
                                      wrote on sidst redigeret af
                                      #130

                                      We're waiting for a brief summary. What does orphan mean for the drug in this context ?

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #131

                                        https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview
                                        https://www.ema.europa.eu/en/human-regulatory/research-development/orphan-designation/orphan-incentives

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #132

                                          Ok thanks,
                                          so it still need to be approved before use

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper